Synthesis and Experimental Validation of New Designed Heterocyclic Compounds with Antiproliferative Activity versus Breast Cancer Cell Lines MCF-7 and MDA-MB-231

<div>Reagents and conditions: (a) ClCH<sub>2</sub>COC<sub>6</sub>H<sub>4</sub>R, EtOH, reflux; (b) PPA, room temperature or H<sub>2</sub>SO<sub>4</sub> conc., 140°C.</div>

Journal of Chemistry

sch1

Scheme 1

Scheme 1: Synthesis and Experimental Validation of New Designed Heterocyclic Compounds with Antiproliferative Activity versus Breast Cancer Cell Lines MCF-7 and MDA-MB-231 

Scheme 1 | Synthesis and Experimental Validation of New Designed Heterocyclic Compounds with Antiproliferative Activity versus Breast Cancer Cell Lines MCF-7 and MDA-MB-231 